What Affects PSA Levels Besides Cancer?

Dozens of factors besides prostate cancer push PSA readings up or down, from something as routine as a prostate exam to less obvious influences like body weight and common medications. PSA is a protein produced mainly by prostate tissue, and anything that irritates, enlarges, manipulates, or changes blood flow to that tissue can shift the number on your lab report. Understanding these influences matters because a single elevated reading can trigger anxiety, repeat testing, and sometimes unnecessary biopsies.

Prostate Enlargement Without Cancer

The single most common reason for an elevated PSA in older men is benign prostatic hyperplasia, the gradual enlargement of the prostate that happens with aging. A larger prostate simply contains more tissue producing PSA, so total output rises. Research has shown that PSA values are strongly correlated with prostate volume, independent of age itself, meaning the gland’s size is doing the heavy lifting rather than aging alone.¹ This is worth knowing because roughly half of men over 50 have some degree of prostate enlargement, and their PSA numbers can easily cross the traditional screening cutoff of 4.0 ng/mL without a trace of malignancy.

Inflammation and Infection

Prostatitis, whether bacterial or the more common asymptomatic variety, is a well-documented PSA elevator. When the prostate becomes inflamed, more PSA leaks from damaged tissue into the bloodstream. Studies of men with asymptomatic (type IV) prostatitis found a strong positive correlation between the extent and grade of inflammation and total PSA levels.² The tricky part is that type IV prostatitis has no symptoms. A man feels fine, gets a blood test, and sees a worrying number that turns out to be inflammation discovered only on biopsy.

Urinary tract infections can similarly elevate PSA, and acute urinary retention, the sudden inability to urinate, has been shown to roughly double PSA levels, an effect that can persist for up to two weeks.³ The practical takeaway is that if you’ve recently had a UTI or a bout of urinary retention, your doctor should ideally wait before ordering a PSA test or interpreting a result drawn during that window.

Ejaculation Before the Test

Sexual activity is one of the more surprising PSA confounders. Ejaculation causes a measurable spike in serum PSA, and the effect is not trivial. In one study of men aged 49 to 79, about 92% returned to their baseline PSA within 24 hours, but the remaining men took up to 48 hours. The researchers recommended abstaining from ejaculation for 48 hours before a blood draw.⁴ A separate study found that 40% of men still had total PSA above baseline at the 24-hour mark when normal biological variation was accounted for.⁵

Not every study agrees on the clinical significance. One trial found that while PSA rose sharply one hour after ejaculation, the difference at 24 hours was no longer statistically significant, especially in men over 50 who were being screened.⁶ Still, the safest advice is to avoid ejaculation for at least a day or two before a scheduled PSA test, particularly if your baseline levels are near a decision threshold.

Digital Rectal Exams and Prostate Biopsies

There is a long-standing question about whether you should have blood drawn before or after a rectal exam. The data say before. After a digital rectal exam, PSA rose above normal biological variation in about a third of men within one hour, and one study documented increases as high as 70%.⁷ Those researchers recommended waiting three days after a rectal exam before drawing PSA. Another study confirmed the effect, noting that a rectal exam had a slight but statistically significant positive effect on total PSA, while free PSA increased more substantially.⁸

Prostate biopsies are a far bigger disruptor. PSA increases ranged from 1.3-fold to 9.5-fold after biopsy, and in most patients the levels had not returned to baseline even five days later.⁷ Total PSA remained elevated for at least a week in most men after needle biopsy.⁸ If you’ve had a biopsy, any PSA drawn in the weeks that follow should be interpreted with that in mind.

Cystoscopy and Catheterization

Rigid cystoscopy, where a stiff scope is passed through the urethra into the bladder, can raise PSA significantly for at least 24 hours.⁹ Flexible cystoscopy also produces a statistically detectable rise, though the actual change in total PSA (around 0.11 ng/mL) is small enough that researchers concluded it was not clinically meaningful.¹⁰

Urethral catheterization, on the other hand, appears not to affect PSA at all in the absence of a urinary tract infection. A study that measured PSA, PSA density, and the free-to-total ratio before and after catheter placement found no significant difference.¹¹ So having a Foley catheter placed in the hospital is unlikely to confound your results as long as infection doesn’t develop.

Cycling and Physical Pressure on the Perineum

Long-distance cycling has been debated for years. One study of men aged 50 and over found that a long bike ride raised total PSA by an average of about 9.5%, and the number of men with PSA above 4.0 ng/mL tripled from two to six.¹² The increase correlated with both age and distance ridden. However, a systematic review pooling the limited available evidence concluded there was no consistent overall effect of cycling on PSA, partly because the studies varied so much in distance, timing of blood draws, and participant age.¹³ The practical advice is modest: if you’re a committed cyclist and your PSA comes back borderline, it’s worth mentioning the hobby to your doctor and considering a repeat test after a rest period.

Medications That Lower PSA

Several widely prescribed drugs push PSA downward, which sounds benign but can actually mask a developing cancer if the suppression is not accounted for.

5-Alpha Reductase Inhibitors

Finasteride and dutasteride, commonly prescribed for an enlarged prostate or hair loss, are the most important PSA suppressors. These drugs roughly halve the PSA reading after about a year of use, a well-established phenomenon that led to the “multiply by two” rule in clinical practice.¹⁴ But the doubling rule isn’t perfect across all time frames. Evidence from the Prostate Cancer Prevention Trial showed that the correction factor needed to rise from 2.0 at 24 months to roughly 2.5 at seven years of finasteride use.¹⁵ Clinicians may also watch for any rise from your lowest point on the drug: an increase of 0.3 ng/mL or more from your nadir has been shown to maintain reasonable sensitivity for detecting cancer in men taking dutasteride.¹⁶

NSAIDs, Statins, and Thiazide Diuretics

Common over-the-counter and prescription drugs can also nudge PSA downward. An analysis of national health survey data found that five years of NSAID use was associated with PSA levels about 6% lower, five years of statin use with levels about 13% lower, and five years of thiazide diuretic use with levels about 26% lower.¹⁷ The evidence is not entirely consistent; a separate study found no clear association between statin or NSAID use and baseline PSA.¹⁸ These effects are modest individually, but for a man taking all three drug classes long-term, the combined suppression could meaningfully lower his apparent PSA.

Testosterone Replacement Therapy

Men receiving testosterone for low hormone levels often worry that therapy will inflate PSA enough to trigger false alarms. A systematic review and meta-analysis found that testosterone-treated men did have slightly higher PSA than controls, but the difference was small, around 0.15 ng/mL overall.¹⁹ The increase was more pronounced with intramuscular injections (about 0.27 ng/mL higher than controls) than with gels or patches. The odds of having an elevated PSA after treatment were similar between testosterone and placebo groups, so the therapy does not appear to push many men over the diagnostic threshold in practice. That said, PSA monitoring is standard during testosterone therapy, and any unexpected jump still warrants a conversation with your doctor.²⁰

Age and the Normal Upward Drift

PSA rises steadily with age in healthy men who never develop cancer. A large community-based study estimated that for a healthy 60-year-old, PSA increases by about 3.2% per year, or roughly 0.04 ng/mL per year.²¹ That same study proposed age-specific reference ranges: up to 2.5 ng/mL for men in their 40s, up to 3.5 in their 50s, up to 4.5 in their 60s, and up to 6.5 in their 70s. A population-based study of elderly men found the upward drift continues, with the 95th percentile climbing from about 4.9 ng/mL in the 60–64 age group to over 33 ng/mL in men 85 and older.²² The age-related rise is mostly driven by increasing prostate volume rather than age itself.²³

Body Weight and Blood Volume

Obesity lowers PSA, which is the opposite of what many men expect. The explanation appears to be hemodilution: men with higher body mass carry a larger blood volume, so the same amount of PSA produced by the prostate gets diluted in a bigger pool of plasma. Research in men undergoing prostate surgery confirmed that higher BMI was associated with higher plasma volume and lower PSA concentrations, even in men who had cancer.²⁴ Follow-up work found that only a fraction of the lower PSA in obese men could be explained by their lower testosterone levels; the rest was attributed to this dilution effect.²⁵ In men with a healthy BMI, PSA tracked positively with hematocrit, further supporting the idea that blood concentration matters.²⁶

This has real-world consequences for cancer screening. Obese men may harbor early cancers that their suppressed PSA fails to flag, potentially delaying diagnosis. Clinicians who screen heavier patients should keep the dilution effect in mind when deciding whether a “normal” PSA truly rules out concern.

Race and Ethnicity

Baseline PSA varies by race even after controlling for prostate size and age. A systematic review covering more than 650,000 men found that Black men without prostate cancer had higher PSA levels than White men, while Hispanic men had levels similar to White men and lower than Black men.²⁷ Earlier work from a single institution reported mean PSA of 2.1 ng/mL in African-American men versus 1.53 ng/mL in White men, a gap that persisted after adjusting for age and prostate volume.²⁸ The reasons are not fully settled; some of the difference likely reflects biological variation in PSA production at the tissue level rather than differences in prostate size. The clinical implication is that the standard PSA cutoffs, developed primarily in White populations, may not be directly applicable to all men.²⁹

Time of Day

PSA has a diurnal rhythm that most men are never told about. A study measuring PSA in the same men in the morning and afternoon found that the vast majority, roughly 87%, had lower values when measured later in the day.³⁰ Morning readings tend to be the highest, so labs typically draw PSA in the morning for consistency. If your test was drawn late in the day, the result may be slightly lower than it would have been at 8 a.m.

Natural Day-to-Day Fluctuation

Even without any identifiable influence, your PSA bounces around from one blood draw to the next simply due to biological variation. In healthy men with PSA below 2 ng/mL, the natural long-term variability for total PSA is about 12–14%, and a change greater than 30% is needed before you can say with 95% confidence that something real has shifted.³¹ The European Biological Variation Study placed within-subject variation for total PSA at about 6.8%, with a reference change value for a real increase of 15–20%.³² In plain terms, a PSA that goes from 3.0 to 3.4 between annual screenings is well within the noise. It does not, by itself, mean anything changed.

Ischemia and Cardiac Events

A less commonly known trigger is reduced blood flow to the prostate. After coronary bypass surgery, researchers observed significant PSA elevations, likely caused by ischemic damage to prostate tissue during the procedure.³³ Even more striking, prolonged CPR, which can cause severe tissue hypoperfusion throughout the body, produced PSA values above the normal range in 63% of male patients studied. Those elevations took about a week to gradually return toward baseline.³⁴ The message for hospitalized patients: PSA drawn soon after a major cardiac event or resuscitation is unreliable for cancer screening.

Herbal Supplements and Saw Palmetto

Saw palmetto is one of the most popular supplements marketed for prostate health, and men sometimes wonder whether it could alter their PSA. A well-designed, placebo-controlled randomized trial (the CAMUS trial) found that increasing doses of saw palmetto extract over 72 weeks did not lower PSA any more than placebo.³⁵ A smaller trial of a phytosterol-enriched saw palmetto formula did report a modest PSA decrease.³⁶ Overall, standard saw palmetto supplements are unlikely to meaningfully alter your PSA, but the supplement market is not standardized, and products vary in composition. If you take any prostate-related supplement, mention it when discussing PSA results.

Free-to-Total PSA Ratio as a Sorting Tool

When your PSA falls in the murky zone between about 4 and 10 ng/mL, doctors often order a free PSA alongside the total. Cancer tends to produce more PSA that binds to blood proteins, while benign conditions tend to produce more free-floating PSA. In a large prospective trial, the median percentage of free PSA was 12% in men who turned out to have cancer and 18% in men with benign disease.³⁷ Using a free PSA cutoff of 25% could have avoided about 20% of unnecessary biopsies in men with benign disease. The ratio loses some of its discriminating power in men with very large prostates (over 60 mL), where the free-to-total ratio becomes similar between benign and malignant cases.³⁸ Both the free-to-total and the complexed-to-total ratio improve diagnostic accuracy compared with total PSA alone.³⁹

PSA From Non-Prostate Tissues

PSA is not exclusively a prostate product. Small amounts are produced by other tissues throughout the body, regulated by steroid hormones. The fluid with the second-highest PSA concentration after seminal fluid is nipple aspirate fluid from the female breast, and the third is breast milk from lactating women.⁴⁰ In clinical practice, these non-prostate sources rarely produce blood levels high enough to confuse screening in men. But the existence of extra-prostatic PSA production is one reason PSA is sometimes detectable, at very low concentrations, in women and even in men who have had their prostate entirely removed. It also occasionally matters in forensic science, where PSA detection is used to identify the presence of seminal fluid, and false positives from breast fluid have been documented.